Matches in Nanopublications for { ?s ?p "[Loss of the Merlin tumour suppressor causes abnormal de-differentiation and proliferation of Schwann cells and formation of schwannoma tumours in patients with neurofibromatosis type 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP341847.RAiBID8ZvN1rIIqHhrjdgqRwdL6lHDp2CFPd1Alae21U0130_assertion description "[Loss of the Merlin tumour suppressor causes abnormal de-differentiation and proliferation of Schwann cells and formation of schwannoma tumours in patients with neurofibromatosis type 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341847.RAiBID8ZvN1rIIqHhrjdgqRwdL6lHDp2CFPd1Alae21U0130_provenance.
- NP759078.RAY_eN01Cq6T_SBxsN7rTrpThHGsbFwmZAXr_o9LfsA4Y130_assertion description "[Loss of the Merlin tumour suppressor causes abnormal de-differentiation and proliferation of Schwann cells and formation of schwannoma tumours in patients with neurofibromatosis type 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP759078.RAY_eN01Cq6T_SBxsN7rTrpThHGsbFwmZAXr_o9LfsA4Y130_provenance.
- assertion description "[Loss of the Merlin tumour suppressor causes abnormal de-differentiation and proliferation of Schwann cells and formation of schwannoma tumours in patients with neurofibromatosis type 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Loss of the Merlin tumour suppressor causes abnormal de-differentiation and proliferation of Schwann cells and formation of schwannoma tumours in patients with neurofibromatosis type 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP759105.RAqQudva7waAEeSo17VFAZ7utUYyOhXnqlykoVaD5Lp7M130_assertion description "[Loss of the Merlin tumour suppressor causes abnormal de-differentiation and proliferation of Schwann cells and formation of schwannoma tumours in patients with neurofibromatosis type 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP759105.RAqQudva7waAEeSo17VFAZ7utUYyOhXnqlykoVaD5Lp7M130_provenance.
- NP1053321.RAbtTgtq6bRS_hKRIJG5GuNFKT4zqwEgt59qXSDWGMj3A130_assertion description "[Loss of the Merlin tumour suppressor causes abnormal de-differentiation and proliferation of Schwann cells and formation of schwannoma tumours in patients with neurofibromatosis type 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1053321.RAbtTgtq6bRS_hKRIJG5GuNFKT4zqwEgt59qXSDWGMj3A130_provenance.
- NP1053322.RAP2vUp74kGdCPIqJxHyr31b_q7MeBd2lCS9T0DbF9LGk130_assertion description "[Loss of the Merlin tumour suppressor causes abnormal de-differentiation and proliferation of Schwann cells and formation of schwannoma tumours in patients with neurofibromatosis type 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1053322.RAP2vUp74kGdCPIqJxHyr31b_q7MeBd2lCS9T0DbF9LGk130_provenance.